Phibro Animal Health Corporation (NASDAQ:PAHC) COO Larry Lee Miller sold 15,891 shares of the stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $36.46, for a total transaction of $579,385.86. Following the completion of the transaction, the chief operating officer now owns 15,891 shares of the company’s stock, valued at $579,385.86. The sale was disclosed in a document filed with the SEC, which is available through this link.

Larry Lee Miller also recently made the following trade(s):

  • On Thursday, September 14th, Larry Lee Miller sold 21,439 shares of Phibro Animal Health Corporation stock. The stock was sold at an average price of $36.43, for a total transaction of $781,022.77.
  • On Tuesday, September 12th, Larry Lee Miller sold 46,102 shares of Phibro Animal Health Corporation stock. The stock was sold at an average price of $36.33, for a total transaction of $1,674,885.66.
  • On Thursday, September 7th, Larry Lee Miller sold 32,459 shares of Phibro Animal Health Corporation stock. The stock was sold at an average price of $35.59, for a total transaction of $1,155,215.81.

Phibro Animal Health Corporation (NASDAQ PAHC) traded down 0.97% during mid-day trading on Friday, reaching $35.75. 267,714 shares of the company’s stock were exchanged. The company’s 50-day moving average is $37.99 and its 200 day moving average is $33.77. Phibro Animal Health Corporation has a one year low of $24.83 and a one year high of $40.25. The firm has a market capitalization of $1.43 billion, a P/E ratio of 22.20 and a beta of 1.36.

Phibro Animal Health Corporation (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, August 30th. The company reported $0.39 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.35 by $0.04. The business had revenue of $194.84 million during the quarter, compared to analyst estimates of $192.47 million. Phibro Animal Health Corporation had a net margin of 8.45% and a return on equity of 47.88%. The company’s quarterly revenue was up 3.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.32 earnings per share. Equities analysts predict that Phibro Animal Health Corporation will post $1.57 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 27th. Shareholders of record on Wednesday, September 6th will be given a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a dividend yield of 1.12%. The ex-dividend date of this dividend is Friday, September 1st. Phibro Animal Health Corporation’s payout ratio is 24.69%.

COPYRIGHT VIOLATION NOTICE: “Phibro Animal Health Corporation (PAHC) COO Sells $579,385.86 in Stock” was posted by American Banking News and is owned by of American Banking News. If you are viewing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright laws. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/09/15/phibro-animal-health-corporation-pahc-coo-sells-579385-86-in-stock.html.

Several brokerages recently issued reports on PAHC. Piper Jaffray Companies reiterated a “buy” rating and issued a $41.00 price target (down from $42.00) on shares of Phibro Animal Health Corporation in a research note on Thursday, August 31st. Credit Suisse Group increased their price target on shares of Phibro Animal Health Corporation from $36.00 to $37.00 and gave the stock an “outperform” rating in a research note on Thursday, August 31st. Bank of America Corporation reiterated an “underperform” rating and issued a $33.00 price target on shares of Phibro Animal Health Corporation in a research note on Wednesday, August 23rd. Finally, BidaskClub lowered shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 23rd. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $34.00.

Hedge funds have recently added to or reduced their stakes in the business. Mason Street Advisors LLC lifted its position in shares of Phibro Animal Health Corporation by 7.1% during the first quarter. Mason Street Advisors LLC now owns 4,333 shares of the company’s stock valued at $122,000 after buying an additional 286 shares during the last quarter. Victory Capital Management Inc. lifted its position in shares of Phibro Animal Health Corporation by 79.2% during the first quarter. Victory Capital Management Inc. now owns 4,573 shares of the company’s stock valued at $129,000 after buying an additional 2,021 shares during the last quarter. State of Alaska Department of Revenue lifted its position in shares of Phibro Animal Health Corporation by 80.9% during the second quarter. State of Alaska Department of Revenue now owns 3,690 shares of the company’s stock valued at $136,000 after buying an additional 1,650 shares during the last quarter. Municipal Employees Retirement System of Michigan lifted its position in shares of Phibro Animal Health Corporation by 3.6% during the second quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after buying an additional 150 shares during the last quarter. Finally, KBC Group NV purchased a new stake in shares of Phibro Animal Health Corporation during the second quarter valued at about $166,000. 48.35% of the stock is owned by institutional investors and hedge funds.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Insider Buying and Selling by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.